The company announced the first close of its Series B round, co-led by Ashish Kacholia and Lashit Sanghvi
4baseCare will deploy the funds to expand in global geographies like the Middle East, Latin America and Southeast Asia
The company is building population-relevant clinico-genomic intelligence to create databases that provide actionable insights to doctors
Healthtech startup 4baseCare
has raised INR 90 Cr ($9.8 Mn) as part of its ongoing Series B funding round. The round was co-led by ace investors Ashish Kacholia and Lashit Sanghvi, while existing investor Yali Capital also participated.
4baseCare, which specialises in precision oncology, will utilise the fresh capital to expand its network across India as well as enter and strengthen its presence in international markets like the Middle East, Southeast Asia, Latin America, and Central Asia.
The startup is building an AI-driven platform to analyse combined clinical and genomic data, tailored for specific use cases to enhance precision medicine, diagnosis, and treatment.
The tech enables 4baseCare to create databases that combine large-scale genomic data with clinical, environmental, and lifestyle information to enhance precision medicine.
It is looking to increase the presence of its hospital-linked genomics labs network to make cancer-care more affordable and attainable.
Additionally, the startup will also deploy the fresh capital toward developing and launching its AI-driven clinical decision support solutions. This includes the OncoTwin Insights, which helps oncologists to access actionable treatment insights from real-world clinico-genomic and outcomes-linked datasets.
The Bengaluru-based startup had earlier raised INR 50 Cr ($5.4 Mn) in a Series A round led by Yali capital. Important to note that Infosys also participated in the round, pouring in INR 8.3 Cr for a minority stake. It had also received a grant from the Karnataka government in 2024.
The investment comes at a time when investors are doubling down on healthtech in India, especially those offering diagnostic abilities and treatment regimes leveraging AI. Many of these companies are also focussing on health and wellness through wearables and full-stack platforms.
According to Inc42’s ‘Annual Indian Startup Trends Report, 2025’, the market for healthtech is projected to grow at 39% CAGR from 2025 to breach the $37 Bn+ mark by 2030, with around $700 Mn raised in 2025.
